Peter Ssebutinde

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Evaluating the feasibility and uptake of a community‐led HIV testing and multi‐disease health campaign in rural Uganda

Jane Kabami, Gabriel Chamie, Dalsone Kwarisiima et al. · Journal of the International AIDS Society · 2017 · 32 citations · Full text

Public Health, Community Health, Health Promotion +17

Implementing clinical guidelines to promote integration of mental health services in primary health care: a qualitative study of a systems policy intervention in Uganda

Edith K. Wakida, Celestino Obua, Seggane Musisi et al. · International Journal of Mental Health Systems · 2019 · 14 citations · Full text

Public Affairs, Health Policy, Mental Health Care +15

Effect of age at initiation of antiretroviral therapy on treatment outcomes; A retrospective cohort study at a large HIV clinic in southwestern Uganda

Peter Ssebutinde, Imelda T. Kyamwanga, Eleanor Turyakira et al. · PLoS ONE · 2018 · 13 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +14

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

Cissy Kityo, David Dunn, Anne Hoppé et al. · Clinical Infectious Diseases · 2018 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17